InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: Venture_Cap post# 81126

Friday, 05/29/2020 12:49:24 AM

Friday, May 29, 2020 12:49:24 AM

Post# of 233240
Sorry for non-functioning link in earlier post on this:

This study is interesting.

https://www.research.manchester.ac.uk/portal/files/73511040/JFM_2018_14_R2_July_4_2018.pdf


It looks at companies that move from the NYSE to the NASDAQ for several reasons. Not having a broker/financial background, I'm still learning. After skimming through it, the reasons seem to fit with CytoDyn probably moving toward NASDAQ.

From what I can see, the NYSE costs the company more for the "prestige" to be listed there. The NASDAQ sounds very appropriate for this situation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News